Background: Imipenem-resistant Acinetobacter baumannii (IRAB) poses a great threat to healthcare systems. Production of carbapenem-hydrolyzing class D b-lactamases (CHDLs) is the major mechanism for imipenem resistance. In this study, we found a high prevalence of IRAB carrying a gene encoding CHDL, bla OxA-23 , in central Taiwan and elucidated the molecular characteristics and possible mechanisms of the spread of these isolates. Methods: During 2007, we collected 291 nonrepetitive A baumannii isolates from 10 teaching hospitals in Taiwan. The antimicrobial susceptibility of the isolates was determined by agar dilution or Etest. The genes encoding carbapenemase and related structure were detected by polymerase chain reaction mapping and sequencing, and the clonal relationship of the isolates was analyzed by pulsed-field gel electrophoresis. Plasmid localization of bla was determined by extraction of plasmid with commercial kit and Southern blot analysis. 
Introduction
Acinetobacter baumannii has emerged as a major pathogen causing a multitude of infections, especially in critically ill, immunosuppressed patients and those treated with broadspectrum antibiotics. 1, 2 Owing to the ability of bacteria to develop different mechanisms of resistance and the increasing number of vulnerable hosts, the prevalence of multidrug resistant A baumannii (MDRAB) rose in the past few decades. Unfortunately, the treatments of choice are limited. 3 The resistance to carbapenem, which was one of the few therapeutic options available, is now a worldwide problem. 4e6 In Taiwan, in 2000, the imipenem-resistant rate in the intensive care units of 5 major hospitals was 22%, 3 whereas in 2010, it was 66.8%. 7 Although resistance to carbapenem has been associated with the loss of outermembrane porins or overexpression of efflux pumps, production of Ambler class B metallo-b-lactamases and carbapenemase-hydrolyzing class D b-lactamases (CHDLs) are the most common mechanisms. 8 Three (bla IMP-like , bla VIM-like , and bla SIM-1 ) of the 6 known metallo-b-lactamases have been identified in IRAB, but these are less prevalent than CHDLs, which include bla OxA-23-like , bla OxA-24-like , bla OxA-51-like , and bla OxA-58-like.
9,10 bla OxA-51-like is intrinsic to A baumannii, while other CHDLs genes were acquired. The distribution of A baumannii carrying these different acquired CHDLs genes varies among different regions and even different hospitals. 11, 12 The most common acquired CHDL gene of imipenem-resistant A baumannii (IRAB) in many Asia-Pacific countries is bla OxA-23 , 13e16 and a high prevalence of bacterial strains carrying bla has been reported in hospitals in central Taiwan. 17, 18 The bla OxA-23 gene can be carried by transposons such as Tn2006, Tn2007, and Tn2008. 19 In this study, we aimed to investigate the distribution and characteristics of A baumannii carrying bla OxA-23 in Taiwan. We also propose possible ways of spreading of bla OxA-23 -carrying stains.
Materials and methods

Bacterial isolates and identification
We collected 367 nonrepetitive isolates of Acinetobacter species from 10 teaching hospitals located in different areas in Taiwan from June 2007 to September 2007 (Fig. 1) . Four hospitals are located in northern (N) Taiwan, 3 in central (C) Taiwan, and 3 in southern (S) Taiwan. The isolates were initially stored at À70 C in trypticase soy broth (Difco Laboratories, Detroit, MI, USA) supplemented with 15% glycerol. The A baumannii species was identified at the Taipei Veterans Hospital, using a multiplex polymerase chain reaction (PCR) method for detection of specific 16SÀ23S rRNA intergenic spacer present in A baumannii as described previously. 20, 21 Those confirmed as A baumannii were selected for further studies.
Antimicrobial susceptibility testing
The minimal inhibitory concentration (MIC) of isolates was determined by the agar dilution method according to the guidelines provided by the Clinical and Laboratory Standards Institute (CLSI) 22 or Etest (bioMérieux, Marcy-L'Etoile, France). Susceptibility was interpreted based on CLSI breakpoints or manufacturer's instructions. Antimicrobials including meropenem, imipenem, colistin, tigecycline, sulbactam, amikacin, ticarcillin, piperacillin, ceftazidime, cefepime, and ciprofloxacin, were tested.
Pulsed-field gel electrophoresis
The clonality of isolates carrying bla OxA-23 was determined with pulsed-field gel electrophoresis (PFGE) as described previously. 11 Briefly, after digestion with ApaI, the DNA fragments were subjected to PFGE in 1% SeaKem Gold agarose gels (Cambrex Bio Science, Rockland, ME, USA) in 0.5Â TBE buffer (45 mM Tris, 45 mM boric acid, 1.0 mM EDTA, pH 8.0). The stained gel was photographed and analyzed by BioNumerics software (Applied Maths, SintMartens-Latem, Belgium) to generate a dendrogram of relatedness among these isolates. Isolates with >85% similarity were grouped as the same clone. 23 
Identification of CHDLs
PCR with primers targeting bla OxA-23-like , bla OxA-24-like , bla OxA-58-like , and bla OxA51-like 24 were used to detect genes encoding common CHDLs. Primers for ISAba1F and OXAlikeR were used to detect the presence of ISAba1 upstream of different carbapenemases genes. 25, 26 Determination of the plasmid localization of bla The plasmid was extracted with plasmid DNA Miniprep Kit (Bioman, Taipei, Taiwan) or a plasmid Maxi Kit (Qiagen, Valencia, CA, USA). The localization of bla OxA-23 was detected by Southern blot. 27 After hybridization with a PCR-generated probe derived from primers targeting bla OxA-23 (5 0 -TTTACTTGCTATGTGGTTG-3 0 and 5 0 -CATTTCT-GACCGCATTTC-3 0 ), the band was visualized by digoxigenin (DIG) DNA labeling and detection kit (Roche Diagnostics, Basel, Switzerland) according to the manufacturer's instructions.
Identification of Tn2006, Tn2007, and Tn2008
PCR mapping was used to detect Tn2006, Tn2007, and Tn2008. Primer locations are shown in Fig. 2 . The common region of Tn2006 and Tn2008 (923 bp, from bla OxA-23 to DATPase) was amplified using primers P3 (Tn2006OXA23; 5'-GTCTATCAGGAACTTGCGCG-3') and P5 (TN2008ATPase; 5'-GGCTCATTACAGTCAGGTACAAGT-3'). PCR for Tn2006 was performed with primers P3 and P4 (Tn2006ISAba1; 5'-GCAAGGCTTTAGATGCAGAAGA-3') to amplify the region (2237 bp) between bla OxA-23 and ISAba1 in Tn2006. PCR targeting ISAba4 (Tn2007) was performed as previously described. 28 Amplified DNA products were resolved by electrophoresis in agarose gels (2% w/v), stained with ethidium bromide, purified according to the manufacturer's instruction, (Geneaid Biotech Ltd, Taipei, Taiwan), and processed for DNA sequencing by a commercial company (Mission Biotech, Taipei, Taiwan).
Consumption of imipenem and meropenem per 100 person-days in different areas
The National Health Insurance program covers 99% of the population in Taiwan. Computerized claims data are collected and stored in the National Health Insurance Research Database by the National Health Research Institute. We retrospectively retrieved inpatients' claim data from 2007. We calculated for each patient the dose of imipenem and meropenem and the total person-day to obtain the defined daily dose per 100 person-day in northern, central, and southern areas, which were defined according to the location of the hospitals. The northern area included Taipei and New Taipei City; the central area included Taichung City and its county and Changhua; and the southern area included Tainan City and its county and Kaohsiung City and its county.
Results
Of 291 isolates confirmed to be A baumannii, 142 (48.8%) were resistant to imipenem. The imipenem-resistance rate in northern, central, and southern Taiwan was 39.3% (42/ 107), 56.9% (62/109), and 50.7% (38/75), respectively. The defined daily doses of carbapenem per 100 person-days in northern, central, and southern areas were 1.43, 1.33, and 1.50, respectively. Among IRAB isolates, 30 (21.1%) harbored bla OxA-23. The prevalence of IRAB with bla OxA-23 was highest in central Taiwan (Fig. 1) , accounting for 24.8% (27/109) of all isolates, compared to that in the northern (2.8%, 3/107) and southern areas (0%, 0/75; both p < 0.001).
Antimicrobial susceptibility testing
The antimicrobial susceptibility tests (Supplementary Table  1 ) revealed that strains carrying bla OxA-23 were also resistant to many other commonly used antimicrobial agents. The resistance rates to ticarcillin, sulbactam, amikacin, ceftazidime, cefepime, piperacillin, imipenem, meropenem, and ciprofloxacin were all higher than 90%. Colistin-resistant isolates were not found. However, the MICs of tigecycline among 9 isolates (30%) were more than 2 mg/L by using Etest.
Detection of other carbapenemase genes and surrounding genetic structure of bla Most of the isolates carrying bla OxA-23 (28, 93 .3%) had ISAba1 upstream the bla oxa-23 gene. All isolates contained bla OxA-51 but only 3, which did not belong to the same clone but were present in the same hospital, had ISAba1 upstream of bla (Fig. 3) . A strain, which did not have ISAba1 preceding the bla OxAÀ23 or bla OxAÀ51 , expressed bla OxAÀ58 , and the MICs of imipenem and meropenem were Figure 2 . Location of primers used for the detection of Tn2006 and Tn2008 in this study. both 32 mg/L. Using primers described in Materials and Methods, we found that the common region of Tn2006 and Tn2008 was detected in all strains, and the region specific for Tn2006 was positive in 22 (73.3%) isolates (Fig. 3) . Tn2008 was present in 6 other isolates (26.7%), whereas bla OxAÀ23 eDATPase but not upstream ISAba1 was present in 2 isolates. No ISAba4 was found, indicating there was no Tn2007 in any of these strains.
Clonal relationship and plasmid study of the isolates
The PFGE analysis showed no major clustering among the isolates (Fig. 3) . Five of the 6 isolates with Tn2008 were collected from the same hospital, and 4 of them belonged to the same clone. Twenty-four isolates were positive for the plasmid, as determined using standard extraction methods. Electrophoresis showed 11 different plasmid patterns (Fig. 3) . Isolates with the same plasmid pattern (e.g., Groups 1, 3, and 4) did not necessarily belong to the same pulsotype, but isolates with the same plasmid pattern were present in the same hospital. Using of the methods described above, the bla OxA-23 gene was detected in plasmids of Group 1, 11, and 6 (data not shown).
Discussion
Our study revealed that bla OxA-23 was mostly found in IRAB isolates collected in central Taiwan, whereas the prevalence of isolates with bla OxA-23 was low in other areas. The presence of Tn2006 and Tn2008 in these isolates together with the diversity of the pulsotypes indicated that the preferred mechanism of spread of bla OxA-23 was via transposons. Clonal spread played a minor role, especially in isolates harboring Tn2008 in Hospital C3. The spread of bla OxA-23 via plasmid dissemination cannot be excluded with the use of current method.
As observed in other Asian countries, 29 our study revealed that the prevalence of IRAB in Taiwan increased in 2007 compared to the rates reported in 2000 3 and 2005. 30 These strains were also resistant to other antimicrobial agents. This resistance resulted in an increased risk of administering inappropriate therapy and therefore was associated with a poor prognosis. 31 Colistin and tigecycline were the main choices for the treatment of infection caused by these IRAB. 9 Although colistin-resistant strains have been emerging in Korea, 32 our survey revealed that colistin retained its activity against these IRAB.
A baumannii strains carrying bla OxA-23 have been discovered worldwide 8 and are prevalent in Asian-Pacific regions.
13e16 In Taiwan, the epidemiology of acquired CHDL genes differed among areas 11, 12 In line with previous studies performed in a single hospital of central Taiwan, 17, 18 bla OxA-23 was the most prevalent CHDL gene in all 3 teaching hospitals in this area and was rarely found in other areas. Although naturally occurring and chromosomelocated bla OxA-51 was discovered in all isolates, ISAba1 carrying the promoter was essential for its contribution to carbapenem resistance. 25 Only three isolates in our study had ISAba1-bla . In contrast, most strains (93.3%) carrying bla OxA-23 had preceding ISAba1, which has been shown to enhance the expression of bla OxA-23 . 33 PFGE studies revealed a minor role of clonal spreading in the dissemination of isolates with bla OxA-23 in A baumannii in Taiwan. In agreement with previous studies, 19 our study indicates that the dissemination of bla 19 Our study also showed that the bla OxA-23 genes were embedded in Tn2006 in most of our isolates. Although Tn2008 has been identified only in one isolate from Libya, it has recently been recognized as the major vehicle carrying bla OxA-23 in China. 34 However, in our study, isolates with this genetic structure only accounted for the minority. Two strains carrying bla OxA-23 had similar structure of Tn2008 but lacked upstream ISAba1. Further studies are warranted for delineating the sequence of the upstream region.
Four isolates with Tn2008 had identical pulsotype and were collected from the same hospital (hospital C3), indicating a clonal spreading. Interestingly, all the isolates bearing Tn2008 had bla OxA-23 detected in plasmids. However, the localization of bla OxA-23 in a large plasmid of other isolates cannot be detected using the currently method. Therefore, the spread of bla OxA-23 via plasmid dissemination cannot be totally excluded.
In conclusion, in this study, we observed a high prevalence of bla in central Taiwan compared with other areas. The bla OxA-23 is disseminated via complex routes. The majority of the strains might acquire bla OxA-23 through the transposition of Tn2006. Clonal spreading played a minor role in the spread of bla . The role of plasmid dissemination needed to be validated.
